113 related articles for article (PubMed ID: 23242319)
1. Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro.
Shi PL; Binnington B; Sakac D; Katsman Y; Ramkumar S; Gariepy J; Kim M; Branch DR; Lingwood C
Toxins (Basel); 2012 Dec; 4(12):1517-34. PubMed ID: 23242319
[TBL] [Abstract][Full Text] [Related]
2. Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.
Saito M; Mylvaganum M; Tam P; Novak A; Binnington B; Lingwood C
J Biol Chem; 2012 May; 287(20):16073-87. PubMed ID: 22418442
[TBL] [Abstract][Full Text] [Related]
3. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms.
Harrison AL; Olsson ML; Jones RB; Ramkumar S; Sakac D; Binnington B; Henry S; Lingwood CA; Branch DR
Glycoconj J; 2010 Jul; 27(5):515-24. PubMed ID: 20582467
[TBL] [Abstract][Full Text] [Related]
4. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
[TBL] [Abstract][Full Text] [Related]
5. A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection.
Lund N; Branch DR; Mylvaganam M; Chark D; Ma XZ; Sakac D; Binnington B; Fantini J; Puri A; Blumenthal R; Lingwood CA
AIDS; 2006 Feb; 20(3):333-43. PubMed ID: 16439866
[TBL] [Abstract][Full Text] [Related]
6. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
Kiarash A; Boyd B; Lingwood CA
J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
[TBL] [Abstract][Full Text] [Related]
7. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
[TBL] [Abstract][Full Text] [Related]
8. The major population of PHA-stimulated PBMC infected by R5 or X4 HIV variants after a single cycle of infection is predominantly composed of CD45RO+CD4+ T lymphocytes.
Holl V; Schmidt S; Aubertin AM; Moog C
Arch Virol; 2007; 152(3):507-18. PubMed ID: 17122895
[TBL] [Abstract][Full Text] [Related]
9. Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels.
Ramkumar S; Sakac D; Binnington B; Branch DR; Lingwood CA
Glycobiology; 2009 Jan; 19(1):76-82. PubMed ID: 18842961
[TBL] [Abstract][Full Text] [Related]
10. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
11. GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death.
Rydze RT; Bhattarai N; Stapleton JT
Antivir Ther; 2012; 17(7):1271-9. PubMed ID: 22951385
[TBL] [Abstract][Full Text] [Related]
12. Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells.
Cameron P; Bingham D; Paul A; Pavelka M; Cameron S; Rotondo D; Plevin R
Infect Immun; 2002 Oct; 70(10):5370-80. PubMed ID: 12228261
[TBL] [Abstract][Full Text] [Related]
13. Verotoxin 1 from Escherichia coli affects Gb3/CD77+ bovine lymphocytes independent of interleukin-2, tumor necrosis factor-alpha, and interferon-alpha.
Menge C; Stamm I; Blessenohl M; Wieler LH; Baljer G
Exp Biol Med (Maywood); 2003 Apr; 228(4):377-86. PubMed ID: 12671182
[TBL] [Abstract][Full Text] [Related]
14. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
15. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.
Head SC; Karmali MA; Lingwood CA
J Biol Chem; 1991 Feb; 266(6):3617-21. PubMed ID: 1847382
[TBL] [Abstract][Full Text] [Related]
16. Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.
Itoh K; Tezuka T; Inoue K; Tada H; Suzuki T
Tohoku J Exp Med; 2001 Dec; 195(4):237-43. PubMed ID: 11908825
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
18. Globotriaosylceramide (Gb(3)/CD77) is synthesized and surface expressed by bovine lymphocytes upon activation in vitro.
Menge C; Stamm I; Wuhrer M; Geyer R; Wieler LH; Baljer G
Vet Immunol Immunopathol; 2001 Nov; 83(1-2):19-36. PubMed ID: 11604159
[TBL] [Abstract][Full Text] [Related]
19. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
